AMRUTANJAN HEALTH CARE
Quarterly Results Analysis [Dec2024]
AMRUTANJAN HEALTH CARE Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹123 Cr | ₹110 Cr | ₹84 Cr | ₹127 Cr | ₹117 Cr | ₹99 Cr | ₹78 Cr | ₹100 Cr |
Expenses | ₹99 Cr | ₹96 Cr | ₹80 Cr | ₹111 Cr | ₹95 Cr | ₹92 Cr | ₹71 Cr | ₹87 Cr |
Operating Income | ₹23 Cr | ₹14 Cr | ₹4 Cr | ₹16 Cr | ₹22 Cr | ₹7 Cr | ₹7 Cr | ₹13 Cr |
Other Income | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹26 Cr | ₹16 Cr | ₹6 Cr | ₹20 Cr | ₹24 Cr | ₹9 Cr | ₹9 Cr | ₹16 Cr |
Profit After Tax | ₹19 Cr | ₹12 Cr | ₹5 Cr | ₹14 Cr | ₹17 Cr | ₹7 Cr | ₹7 Cr | ₹13 Cr |
EPS | ₹6.66 | ₹4.08 | ₹1.60 | ₹4.72 | ₹6.04 | ₹2.37 | ₹2.40 | ₹4.34 |
Industry Peers & Returns | 1W | 1M | 1Y |
AMRUTANJAN HEALTH CARE | 2% | -8% | -10.6% |
SUN PHARMACEUTICAL INDUSTRIES | -3.6% | -8.2% | 5.5% |
DIVIS LABORATORIES | -2.3% | 2.3% | 57.6% |
CIPLA | -0.4% | 5.8% | 1.4% |
TORRENT PHARMACEUTICALS | -1.2% | -9.8% | 16.4% |
DR REDDYS LABORATORIES | -2.8% | -2.7% | -9.5% |
MANKIND PHARMA | -3.6% | -6.5% | 6.4% |
ZYDUS LIFESCIENCES | -2.5% | -3.5% | -2.2% |
LUPIN | -5.5% | -8.5% | 19.6% |
AMRUTANJAN HEALTH CARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 11.68 % |
Y-o-Y | 4.92 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹123 Cr | 11.68 | |
Sep2024 | ₹110 Cr | 31.26 | |
Jun2024 | ₹84 Cr | -34.10 | |
Mar2024 | ₹127 Cr | 8.61 | |
Dec2023 | ₹117 Cr | 17.80 | |
Sep2023 | ₹99 Cr | 27.55 | |
Jun2023 | ₹78 Cr | -22.38 | |
Mar2023 | ₹100 Cr | - |
AMRUTANJAN HEALTH CARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 71.66 % |
Y-o-Y | 8.23 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹23 Cr | 71.66 | |
Sep2024 | ₹14 Cr | 283.37 | |
Jun2024 | ₹4 Cr | -78.15 | |
Mar2024 | ₹16 Cr | -24.74 | |
Dec2023 | ₹22 Cr | 215.27 | |
Sep2023 | ₹7 Cr | -4.40 | |
Jun2023 | ₹7 Cr | -44.85 | |
Mar2023 | ₹13 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 53.63 % |
Y-o-Y | 3.15 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 19.02% | 53.63 | |
Sep2024 | 12.38% | 191.98 | |
Jun2024 | 4.24% | -66.82 | |
Mar2024 | 12.78% | -30.69 | |
Dec2023 | 18.44% | 167.63 | |
Sep2023 | 6.89% | -25.03 | |
Jun2023 | 9.19% | -28.98 | |
Mar2023 | 12.94% | - |
AMRUTANJAN HEALTH CARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 63.15 % |
Y-o-Y | 10.28 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹19 Cr | 63.15 | |
Sep2024 | ₹12 Cr | 155.60 | |
Jun2024 | ₹5 Cr | -66.21 | |
Mar2024 | ₹14 Cr | -21.73 | |
Dec2023 | ₹17 Cr | 154.76 | |
Sep2023 | ₹7 Cr | -2.32 | |
Jun2023 | ₹7 Cr | -44.76 | |
Mar2023 | ₹13 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 46.13 % |
Y-o-Y | 5.09 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 15.68 % | 46.13 | |
Sep2024 | 10.73 % | 94.74 | |
Jun2024 | 5.51 % | -48.74 | |
Mar2024 | 10.75 % | -27.95 | |
Dec2023 | 14.92 % | 116.23 | |
Sep2023 | 6.9 % | -23.42 | |
Jun2023 | 9.01 % | -28.77 | |
Mar2023 | 12.65 % | - |
AMRUTANJAN HEALTH CARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 63.24 % |
Y-o-Y | 10.26 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹6.66 | 63.24 | |
Sep2024 | ₹4.08 | 155.00 | |
Jun2024 | ₹1.6 | -66.10 | |
Mar2024 | ₹4.72 | -21.85 | |
Dec2023 | ₹6.04 | 154.85 | |
Sep2023 | ₹2.37 | -1.25 | |
Jun2023 | ₹2.4 | -44.70 | |
Mar2023 | ₹4.34 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD